Back pain patch private label programs combine a large body-area transdermal laminate with a movement-intensive application zone. A back patch sits across lumbar and thoracic areas that flex, stretch, and sweat through an eight-hour workday, so the active profile, the large-format adhesion, the skin-contact safety, and the destination market's OTC monograph each carry their own validation scope. A brand owner who treats back pain patch private label as a single purchase order misses the formulation matrix, the adhesion window, the labelling matrix, and the documentation carry-forward that the program delivers.
KONGDY has manufactured consumer health patches for 36 years and runs back pain patch private label programs for brand owners across North America, Europe, and Asia. The facility is ISO 22716 GMP certified, FDA registered, and operates in-house analytical, microbiological, and stability laboratories, plus back pain patch-specific large-format adhesion and skin-contact safety testing rigs. The private label program is built on a seven-step path that walks the brand owner from the active selection through the launch inventory, with documentation delivered per step.
This guide walks through the seven private label steps: how to select the active profile, how to lock the artwork, how to plan the documentation, how to design the packaging, how to validate the large-format adhesion, how to lock the reorder cadence, and how to model the working capital cycle.
The first private label step is the active profile and the large-format adhesion selection. The active profile decides the labelling claim and the destination market's OTC monograph. The large-format adhesion decides the consumer's wear experience across a full workday.
KONGDY's back pain patch active library covers menthol, camphor, methyl salicylate, capsicum, lidocaine, and combination profiles with the concentration documented per formulation. The brand owner selects the active profile that matches the destination market's OTC monograph and the consumer profile.
The large-format adhesion window covers 8, 12, and 24 hour profiles with each profile documented against the movement scope, the moisture level, and the post-use residue. KONGDY's large-format adhesion window is validated on the in-house adhesion testing rigs.
The skin-contact safety and the wash-off profile are documented per formulation. KONGDY's safety profile covers the destination market's cosmetic regulation, the irritation potential, and the wash-off procedure.
The active and adhesion selection decision is documented in the private label brief. KONGDY's commercial team supports the decision with the destination market's regulatory scope and the consumer profile.
The second private label step is the artwork lock and the brand registration. The artwork locks the dieline, the language panel, the regulatory text, and the brand mark. The brand registration secures the brand mark and the regulatory label in the destination market.
The artwork dieline is locked at the second private label step. KONGDY's dieline library supports the standard back pain patch sizes, and the artwork refresh capability without tooling change keeps the per-market artwork cost low.
The language panel is selected per destination market. KONGDY supports the multi-language rollout with the language-specific text panel and the regulatory text verification per market.
The regulatory text verification covers the ingredient declaration, the pain-relief claim language, the usage directions, and the warning text. KONGDY's regulatory review supports the brand owner with the destination market's text requirements.
The brand registration process secures the brand mark in the destination market. KONGDY supports the brand registration with the brand mark file, the regulatory label, and the documentation dossier.
The third private label step is the documentation planning per destination market. The documentation scope depends on the destination market, the pain-relief claim language, and the destination market's OTC monograph status.
The ISO 22716 GMP certificate is the foundation. KONGDY's ISO 22716 certification covers patch, gel, balm, and cream formats, audited annually by an accredited certification body.
The FDA cosmetic establishment registration and the EU CPSR support the United States and European Union markets. KONGDY maintains the FDA registration and prepares the CPSR with a qualified safety assessor.
The destination market's OTC monograph review covers the pain-relief claim scope, the active profile limit, and the labelling requirement. KONGDY supports the OTC monograph review per destination market.
The finished product CoA is delivered with each shipment. KONGDY's CoA carries the analyst signature, the QA release signature, and the destination market's specification reference.
The stability protocol and microbiological specification support the destination market's regulatory file. KONGDY's stability chambers are qualified to ICH conditions, with multi-temperature storage and accelerated protocols for the first year.
The fourth and fifth private label steps are the packaging design and the large-format adhesion validation. The packaging design locks the sachet count, the secondary packaging configuration, and the brand mark application. The large-format adhesion validation confirms the consumer's full workday wear experience.
The packaging configuration covers the sachet count per box, the secondary packaging material, and the brand mark application. KONGDY supplies packaging configurations from 1 patch to 30 patches per box, with multi-count sets and premium boxes.
The secondary packaging and the brand mark application are validated at the pilot batch stage. KONGDY's packaging line documents the artwork application procedure and the brand mark verification per configuration.
The large-format adhesion validation is documented per formulation and per adhesion window. KONGDY's adhesion validation covers the adhesion strength, the edge lift resistance, the post-use residue profile, and the skin-contact safety across the full window.
The first commercial run validation covers the converting line verification, the analytical release, the documentation lock, and the launch inventory. KONGDY's first commercial run ships with the CoA, the stability protocol summary, and the destination market's documentation dossier.
The sixth and seventh private label steps are the reorder cadence and the working capital cycle. The reorder cadence documents the rhythm that the brand owner follows to refill the launch inventory. The working capital cycle projects the inventory carrying cost and the reorder point per channel.
The reorder cadence is documented at the first commercial run approval gate. KONGDY's commercial team supports the cadence with the working capital model and the reorder point calculation per channel.
The working capital cycle modeling projects the inventory carrying cost by month. KONGDY's commercial team supports the modeling with the production lead time, the channel sell-through rate, and the safety stock calculation.
The repeat run pricing tier applies the volume step-down to the reorder cadence. KONGDY's repeat run tier supports 50,000 to 500,000 patches per reorder with the step-down documented in the multi-year supply agreement.
The working capital stabilisation captures the reorder rhythm that the brand owner follows to keep the launch inventory stable. KONGDY supports the stabilisation with the reorder trigger and the safety stock formula.
Back pain patch private label programs typically launch in one destination market and then roll out across multiple markets. The rollout sequence, the documentation sequencing, and the artwork refresh cadence determine the total cost and the total time to market.
The launch market selection considers the destination market's OTC monograph, the consumer acceptance profile, and the regulatory scope. KONGDY supports the launch market selection with the regulatory scope and the consumer acceptance data.
The market sequence is documented at the pilot batch approval gate. KONGDY's commercial team supports the sequence planning with the destination market's regulatory scope, the documentation deliverable list, and the lead time per market.
Artwork refresh across markets uses the same dieline and the same printing plates, with the language panel updated. KONGDY supports the artwork refresh without changing the tooling, reducing the per-market artwork cost.
Documentation roll-forward applies the stability data, the change control, and the post-market surveillance across the multi-market rollout. KONGDY's documentation system rolls data forward per market.
Most private label failures trace back to four predictable issues. The list below covers the most common ones and how KONGDY supports the brand owner in avoiding them.
A brand owner who skips the active profile selection gate ends up with a formulation that does not match the destination market's OTC monograph. KONGDY's selection gate documents the active profile, the adhesion window, and the safety profile per formulation.
An artwork refresh without the dieline lock forces a tooling change that the brand owner did not budget. KONGDY's dieline lock at the second private label step freezes the cutting pattern and the artwork refresh scope.
An incomplete OTC monograph review produces a destination market registration rejection. KONGDY's OTC monograph review covers the pain-relief claim scope, the active profile limit, and the labelling requirement per market.
A working capital model gap produces a reorder cadence that runs out of stock or carries excess inventory. KONGDY's working capital model projects the cycle by month with the reorder trigger and the safety stock.
Back pain patch private label cost structure has three components: active cost, converting cost, and documentation cost. The active cost is set by the active profile and the large-format adhesion; the converting cost is set by the production run size and the packaging configuration; the documentation cost is set by the destination market's regulatory file.
Active cost drivers include the active raw material, the formulation matrix, and the carrier non-woven. KONGDY's commercial team returns a tiered active cost per formulation per volume tier.
Converting cost drivers include the production run size, the cutting tolerance, the packaging configuration, and the artwork refresh cadence. KONGDY's converting cost is documented in the quotation and locked for the duration of the program.
Documentation cost drivers include the destination market's regulatory file, the OTC monograph, the stability protocol, and the change control scope. KONGDY's documentation cost is documented per destination market.
The volume tier step-down applies to the entire quantity, not only to the units above the threshold. KONGDY's private label program supports tiered pricing with the step-down documented in the multi-year supply agreement.
Back pain patch private label programs win when the brand owner runs them as a seven-step path with documented gate decisions, artwork lock, and reorder cadence. The brand that treats back pain patch private label as a single purchase order loses the active profile verification, the large-format adhesion validation, the OTC monograph, and the launch timing that the seven-step model delivers.
KONGDY runs back pain patch private label programs under ISO 22716 GMP certification with FDA registration, EU CPSR preparation, in-house analytical, microbiological, and stability laboratories, back pain patch-specific large-format adhesion and skin-contact safety testing rigs, and documented change control. The seven-step engagement model supports the brand owner with active profile selection, artwork lock, documentation deliverable per step, and reorder cadence modeling.
Request KONGDY's back pain patch private label seven-step quotation within 48 hours — share your target market, expected launch volume, active profile preference, and packaging direction, and the commercial team will return tiered active cost, converting line schedule, documentation deliverable list, and the lead time schedule for your launch date.
Book a factory audit or live video tour at KONGDY's ISO 22716 facility to review the back pain patch converting line, the large-format adhesion testing rigs, the analytical laboratory, and the stability chamber room, and request a free sample to validate adhesion duration, skin-contact comfort, and first-impression in your channel. Brand owners planning a launch within two quarters can additionally reserve a pilot batch slot while artwork and documentation work run in parallel.
